Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study

Size: px
Start display at page:

Download "Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study"

Transcription

1 Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study Elizabeth J Mayer-Davis, PhD University of North Carolina at Chapel Hill For the SEARCH Study Group, May 2014 Funded by CDC/DDT and NIH/NIDDK. Mayer- Davis et al, Diabet Med. 2012

2 SEARCH for Diabetes in Youth Scientific Rationale Increase in type 2 diabetes in youth in several populations especially minority Increase in type 1 diabetes incidence reported worldwide limited US data Reports of atypical diabetes with mixed phenotypes in youth 2

3 SEARCH Study Sites Seattle Children s Hospital Kaiser Permanente Southern California Cincinnati Children s Hospital Medical Center «South Carolina (Coordinated at UNC Chapel Hill) «Wake Forest School of Medicine (Coordinating Center) University of Washington (Central Laboratory) 3

4 Burden of Diabetes in US Youth Applied to US Census data, SEARCH estimated: 191,986 youth (age 0-19 yr) in the US had physiciandiagnosed diabetes in ,984 with T1D; 20,262 with T2D; 4,740 with other types ~18,400 youth are diagnosed with T1D each year ~5,100 youth are diagnosed with T2D each year Pettitt DJ et al., Diabetes Care 37: 2014; SEARCH Study Group, JAMA 2007; Lawrence et al, in review 4

5 Trends in T1D Prevalence, Prevalence per 1, % relative increase N= 4958 cases in 2001 N= 6666 cases in 2009 p< p< Overall Female Male NHW AA H API AI Dabelea and Mayer-Davis et al; JAMA May 7,

6 Trends in T2D Prevalence, , Among Youth Age Years Prevalence per 1, p< % relative increase N= 588 cases in 2001 N=819 cases in 2009 p< p< p< p< p= p=0.023 p< Overall Female Male NHW AA HISP API AI Dabelea and Mayer-Davis et al; JAMA May 7,

7 Prevalence of Poor Glycemic Control (A1c 9.0%) Race/Ethnicity Type 1 (%) Type 2 (%) Non- Hispanic White African- American Hispanic Asian / Pacific Islander NaJve American Petitti et al., J Peds,

8 Prevalence of Cardiovascular Risk Factors in Youth with Diabetes 100 Type 1 Type 2 80 Percent BP TG HDL Waist MetS MetS: > 2 CVD risk factors Rodriguez, et al, Diabetes Care,

9 Diabetes Metab 33: , 2007; Diabetes Care 29: , 2006; Control Clin Trials 25: , Diabetic Retinopathy (DR) Rationale and Objective Previous Prevalence Estimates For Type 1 diabetes (T1D): Range from 4.6% among youth in France to 20% among youth in Australia For Type 2 diabetes (T2D): 4% (n=25, mean duration 1.3 years) among youth from Australia SEARCH Pilot Study Objective: To assess the feasibility of assessment, and the prevalence of DR in the large, diverse cohort of youth with T1D and T2D in the US

10 Methods Data collection period December 2009 through September 2010 Participant characteristics Previous participation in SEARCH Diabetes duration > 5 years 225 individuals with T1D 179 non-hispanic white, 46 other 69 individuals with T2D 19 non-hispanic white, 50 other 10

11 Methods Assessment of DR Retinal images were obtained by non-mydriatic camera (Zeiss Visucam Pro NM) DR was determined by grading 45 color digital fundus images, centered on macula; both eyes Photo grading was conducted at the University of Wisconsin Ocular Epidemiology Reading Center Severity of DR was based on the worse eye Categorized as None, Minimal Non-Proliferative DR (NPDR), Mild-Moderate NPDR, or Proliferative (PDR) 11

12 Prevalence of Diabetic Retinopathy: Pilot Study PREVALENCE Prevalence n= Non-Hispanic White None Min DR Mild/Mod/PDR None Min DR Mild/Mod/PDR TYPE 1 diabetes Other Race/Ethnicity % for T1D (n=225) 49% for T2D (n=69) 4 16 TYPE 2 diabetes

13 Risk Factors for DR: SEARCH Pilot Study Risk Factor Odds RaJo (95% CI) P- Value Diabetes Type (Type 2 vs. Type 1) Race/Ethnicity (Non- white vs. NHW) HbA1c (%) 1.50 (0.58, 3.88) (0.97, 4.33) 0.06 No DR DR, Any Severity P- Value* 8.6 (70 mmol/mol) 9.4 (79 mmol/mol) Systolic Blood Pressure (mmhg) Diastolic Blood Pressure (mmhg) Log Albumin- to- CreaJnine RaJo LDL Cholesterol (mg/dl) HDL Cholesterol (mg/dl) Log Triglycerides *adjusted for diabetes type, race/ethnicity, durajon, HbA1c, gender, age, and parental educajon

14 What s Next? SEARCH Cohort Study Prevalence, incidence and correlates of diabetes complications: Subclinical macrovascular disease Nephropathy Neuropathy Retinopathy and retinal vessel caliber Data collection underway: ~ 2000 youth/young adults examined thus far ~ 3000 total anticipated by March

15 Thank You SEARCH Study Participants and Their Families SEARCH Principal Investigators Beth Mayer-Davis, PhD, Carolinas Site, Study Co-Chair Dana Dabelea, MD, PhD, Colorado and Native American Site PI, Study Co-Chair Larry Dolan, MD, Ohio Site PI Jean Lawrence, ScD, MPH, MSSA, California Site PI Cate Pihoker, MD, Washington Site PI Santica Marcovina, PhD, ScD, Central Laboratory PI Ronny Bell, PhD, Ralph D Agostino, Jr., PhD, Coordinating Center Co-PIs Giuseppina Imperatore, MD, PhD, Sharon Saydah, PhD, CDC Barbara Linder, MD, PhD, NIDDK 15

16 Back-up Info 16

17 Registry Study Design PREVALENT to date* Prevalent 2001 T1D: 5,323 Prevalent 2001 T2D: 712 Prevalent 2009 T1D: 6,679 Prevalent 2009 T2D: 827 INCIDENT to date* Incident T1D: 12,091 Incident T2D: 3,282 * As of 3/25/2014 In person visit (IPV) IPV Proposed IPV Prevalence Proposed SEARCH 1 SEARCH 2 SEARCH 3 SEARCH 4 17

Racial and ethnic disparities in type 2 diabetes

Racial and ethnic disparities in type 2 diabetes Racial and ethnic disparities in type 2 diabetes Nisa M. Maruthur, MD, MHS Assistant Professor of Medicine & Epidemiology Welch Center for Prevention, Epidemiology, & Clinical Research The Johns Hopkins

More information

Diabetes: The Numbers

Diabetes: The Numbers Diabetes: The Numbers Changing the Way Diabetes is Treated. What is Diabetes? Diabetes is a group of diseases characterized by high levels of blood glucose (blood sugar) Diabetes can lead to serious health

More information

Improving Diabetes Care for All New Yorkers

Improving Diabetes Care for All New Yorkers Improving Diabetes Care for All New Yorkers Lynn D. Silver, MD, MPH Assistant Commissioner Bureau of Chronic Disease Prevention and Control Diana K. Berger, MD, MSc Medical Director Diabetes Prevention

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO

Diabetes and Obesity in Children. Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO Diabetes and Obesity in Children Janie Berquist, RN, BSN, MPH, CDE Children s Mercy Hospitals and Clinics Kansas City, MO Diabetes and Obesity in Children What is Diabetes? How are Diabetes and Obesity

More information

Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study

Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study Trends in the Prevalence of Ketoacidosis at Diabetes Diagnosis: The SEARCH for Diabetes in Youth Study WHAT S KNOWN ON THIS SUBJECT: Diabetic ketoacidosis (DKA) is a life-threatening condition and often

More information

Diabetes Complications

Diabetes Complications Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation

More information

Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009

Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009 Research Original Investigation Prevalence of Type 1 and Type 2 Among Children and Adolescents From 2001 to 2009 Dana Dabelea, MD, PhD; Elizabeth J. Mayer-Davis, PhD; Sharon Saydah, PhD; Giuseppina Imperatore,

More information

Ethnic Disparities and Diabetes Outcomes at Greene County Health Care

Ethnic Disparities and Diabetes Outcomes at Greene County Health Care Community Partners HealthNet Occasional Papers, Number 1 Ethnic Disparities and Diabetes Outcomes at Greene County Health Care D. Alden Smith, MBA; Ying Yang, MSCS; Elie Osta, MD Abstract Objective: The

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

2012 Georgia Diabetes Burden Report: An Overview

2012 Georgia Diabetes Burden Report: An Overview r-,, 2012 Georgia Diabetes Burden Report: An Overview Background Diabetes and its complications are serious medical conditions disproportionately affecting vulnerable population groups including: aging

More information

Demonstration Study of Healthcare Utilization by Obese Patients. Joseph Vasey PhD Director, Epidemiology Quintiles Outcome May 22, 2013

Demonstration Study of Healthcare Utilization by Obese Patients. Joseph Vasey PhD Director, Epidemiology Quintiles Outcome May 22, 2013 Demonstration Study of Healthcare Utilization by Patients Joseph Vasey PhD Director, Epidemiology Quintiles Outcome May 22, 2013 Copyright 2013 Quintiles Revised April 2013 Introduction Obesity in the

More information

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.

Treatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections. National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.

More information

Rural Disparities in posthospitalization. after traumatic brain injury.

Rural Disparities in posthospitalization. after traumatic brain injury. Rural Disparities in posthospitalization rehabilitation after traumatic brain injury. Ashley D Meagher MD, Jennifer Doorey MS, Christopher Beadles MD PhD, Anthony Charles MD MPH University of North Carolina

More information

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study

DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What

More information

Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.

Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes. Diabetes Brief What is Diabetes? Diabetes mellitus is a disease of abnormal carbohydrate metabolism in which the level of blood glucose, or blood sugar, is above normal. The disease occurs when the body

More information

Cardiovascular Disease in Diabetes

Cardiovascular Disease in Diabetes Cardiovascular Disease in Diabetes Where Do We Stand in 2012? David M. Kendall, MD Distinguished Medical Fellow Lilly Diabetes Associate Professor of Medicine University of MInnesota Disclosure - Duality

More information

WILL EQUITY BE ACHIEVED THROUGH HEALTH CARE REFORM? John Z. Ayanian, MD, MPP

WILL EQUITY BE ACHIEVED THROUGH HEALTH CARE REFORM? John Z. Ayanian, MD, MPP WILL EQUITY BE ACHIEVED THROUGH HEALTH CARE REFORM? John Z. Ayanian, MD, MPP Brigham and Women s Hospital Harvard Medical School Harvard School of Public Health BWH Patient-Centered Outcomes Seminar April

More information

Connecticut Diabetes Statistics

Connecticut Diabetes Statistics Connecticut Diabetes Statistics What is Diabetes? State Public Health Actions (1305, SHAPE) Grant March 2015 Page 1 of 16 Diabetes is a disease in which blood glucose levels are above normal. Blood glucose

More information

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation

More information

Diabetes Prevention in Latinos

Diabetes Prevention in Latinos Diabetes Prevention in Latinos Matthew O Brien, MD, MSc Assistant Professor of Medicine and Public Health Northwestern Feinberg School of Medicine Institute for Public Health and Medicine October 17, 2013

More information

Facts about Diabetes in Massachusetts

Facts about Diabetes in Massachusetts Facts about Diabetes in Massachusetts Diabetes is a disease in which the body does not produce or properly use insulin (a hormone used to convert sugar, starches, and other food into the energy needed

More information

Racial Disparities in US Healthcare

Racial Disparities in US Healthcare Racial Disparities in US Healthcare Paul H. Johnson, Jr. Ph.D. Candidate University of Wisconsin Madison School of Business Research partially funded by the National Institute of Mental Health: Ruth L.

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the

More information

Coronary Heart Disease (CHD) Brief

Coronary Heart Disease (CHD) Brief Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs

More information

Low diabetes numeracy predicts worse glycemic control

Low diabetes numeracy predicts worse glycemic control Low diabetes numeracy predicts worse glycemic control Kerri L. Cavanaugh, MD MHS, Kenneth A. Wallston, PhD, Tebeb Gebretsadik, MPH, Ayumi Shintani, PhD, MPH, Darren DeWalt, MD MPH, Michael Pignone, MD

More information

The Burden and Treatment of Diabetes in Elderly Individuals in the U.S.

The Burden and Treatment of Diabetes in Elderly Individuals in the U.S. Epidemiology/Health Services/Psychosocial Research O R I G I N A L A R T I C L E The Burden and Treatment of Diabetes in Elderly Individuals in the U.S. ELIZABETH SELVIN, PHD, MPH 1,2 JOSEF CORESH, MD,

More information

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.

Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant

More information

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING

More information

Diabetes. African Americans were disproportionately impacted by diabetes. Table 1 Diabetes deaths by race/ethnicity CHRONIC DISEASES

Diabetes. African Americans were disproportionately impacted by diabetes. Table 1 Diabetes deaths by race/ethnicity CHRONIC DISEASES Diabetes African Americans were disproportionately impacted by diabetes. African Americans were most likely to die of diabetes. People living in San Pablo, Pittsburg, Antioch and Richmond were more likely

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

2013 Diabetes and Eye Disease Fact Sheet

2013 Diabetes and Eye Disease Fact Sheet The Georgia Department of Public Health 2013 Diabetes and Eye Disease Fact Sheet Diabetes is the leading cause of new cases of blindness among United States adults. 1-3 As Georgia s population ages and

More information

African Americans & Cardiovascular Diseases

African Americans & Cardiovascular Diseases Statistical Fact Sheet 2013 Update African Americans & Cardiovascular Diseases Cardiovascular Disease (CVD) (ICD/10 codes I00-I99, Q20-Q28) (ICD/9 codes 390-459, 745-747) Among non-hispanic blacks age

More information

The Long-term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy

The Long-term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy The Long-term Effects of Laser Photocoagulation Treatment in Patients with Diabetic Retinopathy The Early Treatment Diabetic Retinopathy Follow-up Study Emily Y. Chew, MD, 1 Frederick L. Ferris III, MD,

More information

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.

TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D. TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

ISLET TRANSPLANT APPLICATION FORM

ISLET TRANSPLANT APPLICATION FORM 5/2014 Page 1 of 17 ISLET TRANSPLANT APPLICATION FORM INSTRUCTIONS: This application and the information you provide will be used to determine if you are able to participate in an islet transplant trial

More information

Understanding diabetes Do the recent trials help?

Understanding diabetes Do the recent trials help? Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.

More information

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,

More information

MY TYPE 2 DIABETES NUMBERS

MY TYPE 2 DIABETES NUMBERS BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,

More information

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18

More information

Kelly Goode, PharmD, BCPS, FAPhA, FCCP and Lisa Price Stevens, MD, MPH, FACP

Kelly Goode, PharmD, BCPS, FAPhA, FCCP and Lisa Price Stevens, MD, MPH, FACP Kelly Goode, PharmD, BCPS, FAPhA, FCCP and Lisa Price Stevens, MD, MPH, FACP Objec&ves Describe Diabetes Awareness Program Provide Tools for Program Implementation at Other Sites Describe Shared Care Model

More information

Telemedicine in Prevention and Chronic Disease Management

Telemedicine in Prevention and Chronic Disease Management Telemedicine in Prevention and Chronic Disease Management William P. Santamore, PhD, Alfred A. Bove, MD, PhD Carol Homko, PhD, Temple University Telemedicine Research Center Philadelphia, PA AHRQ June

More information

Technology Assessment

Technology Assessment Technology Assessment Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer Technology Assessment Program Prepared for: Agency for Healthcare

More information

Educational Attainment of Veterans: 2000 to 2009

Educational Attainment of Veterans: 2000 to 2009 Educational Attainment of Veterans: to 9 January 11 NCVAS National Center for Veterans Analysis and Statistics Data Source and Methods Data for this analysis come from years of the Current Population Survey

More information

Electronic Health Records in an Integrated Delivery System: Effects on Diabetes Care Quality

Electronic Health Records in an Integrated Delivery System: Effects on Diabetes Care Quality Electronic Health Records in an Integrated Delivery System: Effects on Diabetes Care Quality Mary Reed, DrPH 1 Jie Huang, PhD 1 Ilana Graetz 1 Richard Brand, PhD 2 Marc Jaffe, MD 3 Bruce Fireman, MA 1

More information

National Diabetes Fact Sheet, 2011

National Diabetes Fact Sheet, 2011 National Diabetes Fact Sheet, 2011 FAST FACTS ON DIABETES Diabetes affects 25.8 million people 8.3% of the U.S. population DIAGNOSED 18.8 million people UNDIAGNOSED 7.0 million people All ages, 2010 Citation

More information

Rethrowing Health Care Disadvantages in North Carolina

Rethrowing Health Care Disadvantages in North Carolina PEER-REVIEWED ARTICLE Racial/Ethnic Differences in Quality of Care for North Carolina Medicaid Recipients C. Annette DuBard, MD, MPH; Angie Yow, RN; Susan Bostrom, RN; Emad Attiah, MSc; Brad Griffith,

More information

Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy

Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Robert Okwemba, BSPHS, Pharm.D. 2015 Philadelphia College of Pharmacy Judith Long, MD,RWJCS Perelman School of Medicine Philadelphia Veteran Affairs Medical Center Background Objective Overview Methods

More information

Causes, incidence, and risk factors

Causes, incidence, and risk factors Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,

More information

Racial and Ethnic Disparities in Women s Health Coverage and Access To Care Findings from the 2001 Kaiser Women s Health Survey

Racial and Ethnic Disparities in Women s Health Coverage and Access To Care Findings from the 2001 Kaiser Women s Health Survey March 2004 Racial and Ethnic Disparities in Women s Health Coverage and Access To Care Findings from the 2001 Kaiser Women s Health Survey Attention to racial and ethnic differences in health status and

More information

C-Reactive Protein and Diabetes: proving a negative, for a change?

C-Reactive Protein and Diabetes: proving a negative, for a change? C-Reactive Protein and Diabetes: proving a negative, for a change? Eric Brunner PhD FFPH Reader in Epidemiology and Public Health MRC Centre for Causal Analyses in Translational Epidemiology 2 March 2009

More information

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014 JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates January 30, 2014 GOALS Review key recommendations from recently published guidelines on blood pressure and cholesterol management Discuss

More information

Methods for Targeting and Evaluating Program Locations to Serve High-Need Youth

Methods for Targeting and Evaluating Program Locations to Serve High-Need Youth Bridging the Gaps: Eliminating Disparities in Teen Pregnancy and Sexual Health June 4-6, 2014 Methods for Targeting and Evaluating Program Locations to Serve High-Need Youth Mary Campa, Ph.D., California

More information

Quantifying Life expectancy in people with Type 2 diabetes

Quantifying Life expectancy in people with Type 2 diabetes School of Public Health University of Sydney Quantifying Life expectancy in people with Type 2 diabetes Alison Hayes School of Public Health University of Sydney The evidence Life expectancy reduced by

More information

ARE FLORIDA'S CHILDREN BORN HEALTHY AND DO THEY HAVE HEALTH INSURANCE?

ARE FLORIDA'S CHILDREN BORN HEALTHY AND DO THEY HAVE HEALTH INSURANCE? infant mortality rate per 1,000 live births ARE FLORIDA'S CHILDREN BORN HEALTHY AND DO THEY HAVE HEALTH INSURANCE? Too Many of Florida's Babies Die at Birth, Particularly African American Infants In the

More information

Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)

Managing diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic

More information

Using an EMR to Improve Quality of Care in a National Network

Using an EMR to Improve Quality of Care in a National Network Using an EMR to Improve Quality of Care in a National Network James M. Gill, MD, MPH Associate Professor of Family Medicine Senior Scientist in Health Policy Jefferson Medical College, Philadelphia, PA

More information

Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care

Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage

More information

Unique Divorce Factors Affecting Children with Type 1 Diabetes. Leesa A. McBroom, PhD, APRN, FNP-C

Unique Divorce Factors Affecting Children with Type 1 Diabetes. Leesa A. McBroom, PhD, APRN, FNP-C Unique Divorce Factors Affecting Children with Type 1 Diabetes Leesa A. McBroom, PhD, APRN, FNP-C Crude Divorce Rates By Country Country Marriage Rate Divorce Rate Divorce Percentage Australia 5.5 2.3

More information

Understanding the Science of Type 2 Diabetes. Anne Westbrook and April Gardner NABT Dallas, TX November 1, 2012

Understanding the Science of Type 2 Diabetes. Anne Westbrook and April Gardner NABT Dallas, TX November 1, 2012 Understanding the Science of Type 2 Diabetes Anne Westbrook and April Gardner NABT Dallas, TX November 1, 2012 Biological Sciences Curriculum Study (BSCS) Founded in 1958 as a curriculum study Committed

More information

Clinician Guide: Bridges to Excellence Diabetes Care Recognition Program

Clinician Guide: Bridges to Excellence Diabetes Care Recognition Program Clinician Guide: Bridges to Excellence Diabetes Care Recognition Program Health Care Incentives Improvement Institute 13 Sugar Street Newtown, CT 06470 bteinformation@bridgestoexcellence.org http://www.hci3.org

More information

Guidelines for the management of hypertension in patients with diabetes mellitus

Guidelines for the management of hypertension in patients with diabetes mellitus Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes

More information

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Challenges in Glycemic Control in Adult and Geriatric Patients Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Provide an overview of diabetes prevalence; discuss challenges and barriers

More information

Risk factors and complications of type 2 diabetes in Asians

Risk factors and complications of type 2 diabetes in Asians Risk factors and complications of type 2 diabetes in Asians Rajbharan Yadav, Pramil Tiwari* and Ethiraj Dhanaraj Department of Pharmacy Practice National Institute of Pharmaceutical Education and Research

More information

Diabetes Care 2011-2012

Diabetes Care 2011-2012 Clinical Innovations in the Patient Centered Medical Home to Improve Diabetes Care Robert A. Gabbay, MD, PhD, FACP Chief Medical Officer & Senior Vice President Joslin Diabetes Center Harvard Medical School

More information

Understanding Diseases and Treatments with Canadian Real-world Evidence

Understanding Diseases and Treatments with Canadian Real-world Evidence Understanding Diseases and Treatments with Canadian Real-world Evidence Real-World Evidence for Successful Market Access WHITEPAPER REAL-WORLD EVIDENCE Generating real-world evidence requires the right

More information

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized

More information

Administrative Council July 28, 2010 Presented by Nancy McNerney Institutional Effectiveness Planning and Research

Administrative Council July 28, 2010 Presented by Nancy McNerney Institutional Effectiveness Planning and Research Administrative Council July 28, 2010 Presented by Nancy McNerney Institutional Effectiveness Planning and Research Developmental Students Today I will talk about 1. Who are they? 2. What are some facts

More information

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA

EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA EXPANDING THE EVIDENCE BASE IN OUTCOMES RESEARCH: USING LINKED ELECTRONIC MEDICAL RECORDS (EMR) AND CLAIMS DATA A CASE STUDY EXAMINING RISK FACTORS AND COSTS OF UNCONTROLLED HYPERTENSION ISPOR 2013 WORKSHOP

More information

Selected Socio-Economic Data. Baker County, Florida

Selected Socio-Economic Data. Baker County, Florida Selected Socio-Economic Data African American and White, Not Hispanic www.fairvote2020.org www.fairdata2000.com 5-Feb-12 C03002. HISPANIC OR LATINO ORIGIN BY RACE - Universe: TOTAL POPULATION Population

More information

The Burden of Diabetes in North Carolina: Brief 2013 Report

The Burden of Diabetes in North Carolina: Brief 2013 Report NC Diabetes Prevention and Control Program Fact Sheet The Burden of Diabetes in North Carolina: Brief 2013 Report Highlights 10.9 percent or 788,000 adults in North Carolina had diabetes in 2011 1. Another

More information

Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care

Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care Anna Satcher Johnson, MPH Symposium on Measuring the HIV Care Continuum Center for AIDS Research University of Washington

More information

David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010

David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010 David Shu, MD, FRCPC Endocrinology, Royal Columbian Hospital October 8 th, 2010 Objectives At the end of the talk, the participants will be able to: 1. Identify the increasing prevalence of type 2 diabetes

More information

Diabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12

Diabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12 Diabetes Introduction The attached paper is adapted from the initial background paper on Diabetes presented to the Capital and Coast District Health Board Community and Public Health Advisory Committee

More information

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine Disclosures & Relevant Relationships I have nothing to disclose No financial conflicts Editor,

More information

High School Graduation Rates in Maryland Technical Appendix

High School Graduation Rates in Maryland Technical Appendix High School Graduation Rates in Maryland Technical Appendix Data All data for the brief were obtained from the National Center for Education Statistics Common Core of Data (CCD). This data represents the

More information

How To Know If You Have Microalbuminuria

How To Know If You Have Microalbuminuria 3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate

More information

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Cohort Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E. Blindness Heart Disease Strokes Kidney Failure Amputation

D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E. Blindness Heart Disease Strokes Kidney Failure Amputation D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E Diabetes is a serious disease that can lead to Blindness Heart Disease Strokes Kidney Failure Amputation Diabetes kills almost 210,000 people

More information

HEDIS CY2012 New Measures

HEDIS CY2012 New Measures HEDIS CY2012 New Measures TECHNICAL CONSIDERATIONS FOR NEW MEASURES The NCQA Committee on Performance Measurement (CPM) approved five new measures for HEDIS 2013 (CY2012). These measures provide feasible

More information

Overview and update of modern type 2 Diabetes philosophy and management. Dr Steve Stanaway Consultant Endocrinologist BCU

Overview and update of modern type 2 Diabetes philosophy and management. Dr Steve Stanaway Consultant Endocrinologist BCU Overview and update of modern type 2 Diabetes philosophy and management Dr Steve Stanaway Consultant Endocrinologist BCU Diabetes economics 2009: 2.6M adults with DM in UK (90% type 2) 2025: est. > 4M

More information

Scottish Diabetes Survey 2014. Scottish Diabetes Survey Monitoring Group

Scottish Diabetes Survey 2014. Scottish Diabetes Survey Monitoring Group Scottish Diabetes Survey 2014 Scottish Diabetes Survey Monitoring Group Contents Table of Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 21 Duration

More information

Using electronic medical record system (EMRS) for diabetes management in Cameroon

Using electronic medical record system (EMRS) for diabetes management in Cameroon HELINA SOCIM Using electronic medical record system (EMRS) for diabetes management in Cameroon MPH, PhD (cand.): Cameroon Diaspora Network.Germany Dr. med. Simeon Choukem: Douala General Hospital Dr. med.

More information

DIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs

DIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs DIABETES CARE What happens if you follow the Alphabet Strategy? As patients reach their targets, the chances of developing serious complications of diabetes will be reduced! 1 Stroke Eye disease Heart

More information

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks

Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Background: Insulin degludec (Tresiba) for the Management of Diabetes: Effectiveness, Value, and Value-Based Price Benchmarks Final Background and Scope November 19, 2015 The Centers for Disease Control

More information

YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels

YOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels YOUR GUIDE TO Managing and Understanding Your Cholesterol Levels Our goal at the Mercy Health Heart Institute is to help you be well. Our experienced team includes cardiologists, cardiovascular surgeons,

More information

Know your Numbers The D5 Goals for Diabetes Care. Shelly Hanson RN, CNS, CDE Cuyuna Regional Medical Center November 6, 2014

Know your Numbers The D5 Goals for Diabetes Care. Shelly Hanson RN, CNS, CDE Cuyuna Regional Medical Center November 6, 2014 Know your Numbers The D5 Goals for Diabetes Care Shelly Hanson RN, CNS, CDE Cuyuna Regional Medical Center November 6, 2014 The D5 What is it 5 different treatment goals identified for optimal diabetes

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting

Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Mortality Assessment Technology: A New Tool for Life Insurance Underwriting Guizhou Hu, MD, PhD BioSignia, Inc, Durham, North Carolina Abstract The ability to more accurately predict chronic disease morbidity

More information

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus

Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,

More information

Public Health Workforce Interests and Needs Survey Presentation at Keeneland, 2015

Public Health Workforce Interests and Needs Survey Presentation at Keeneland, 2015 Public Health Workforce Interests and Needs Survey Presentation at Keeneland, 2015 Katie Sellers, DrPH CPH ASTHO JP Leider, PhD de Beaumont Foundation Kiran Bharthapudi, PhD ASTHO Rivka Liss Levinson,

More information

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery

The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke

More information

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins

Trends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins Type 2 Diabetes Type 2 diabetes is the most common form of diabetes, accounting for 90 95% of cases. 1 Charts 1 and 2 reflect the effect of increasing prevalence on prescribing and costs of products used

More information

Original Article. Risk factors for diabetic retinopathy in selfreported rural population with diabetes

Original Article. Risk factors for diabetic retinopathy in selfreported rural population with diabetes Original Article www.jpgmonline.com Risk factors for diabetic retinopathy in selfreported rural population with diabetes Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T Vision Research

More information

Using the Concept of Being Safe as a Positive Motivator In Diabetes Education

Using the Concept of Being Safe as a Positive Motivator In Diabetes Education Inova Health System Using the Concept of Being Safe as a Positive Motivator In Diabetes Education Ann Carnes MN RN CDE Sally Guise RD CDE AADE Annual Meeting August 6, 2009 Why Safety? 67% of Americans

More information

The Evaluation of Screening Policies for Diabetic Retinopathy using Simulation

The Evaluation of Screening Policies for Diabetic Retinopathy using Simulation The Evaluation of Screening Policies for Diabetic Retinopathy using Simulation R. Davies 1, S.C. Brailsford 1, P.J. Roderick 2 and C.R.Canning 3 1 School of Management, University of Southampton, UK 2

More information

Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075

Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date

More information

Improving Diabetes Care among Low-Income North Carolinians: Project IDEAL

Improving Diabetes Care among Low-Income North Carolinians: Project IDEAL ARTICLE Improving Diabetes Care among Low-Income North Carolinians: Project IDEAL Ronny A. Bell, PhD, MS, Fabian Camacho, MS, Vanessa T. Duren-Winfield, MS, Denise E. Bonds, MD, Roger T. Anderson, PhD,

More information

Health Innovation Challenge - Chronic Disease Management. Haley Augustine & Rakesh Gupta Dalhousie University: Medical School

Health Innovation Challenge - Chronic Disease Management. Haley Augustine & Rakesh Gupta Dalhousie University: Medical School Haley Augustine & Rakesh Gupta 1 Health Innovation Challenge - Chronic Disease Management Haley Augustine & Rakesh Gupta Dalhousie University: Medical School Professor: Lynette Reid, lynette.reid@dal.ca

More information